The Ketamine Breakthrough: How to Find Freedom from Depression, Lift Anxiety and Open Up to a New World of Possibilities

The use of ketamine as a treatment for depression, anxiety, PTSD, and other mental illnesses is discussed in the book "The Ketamine Breakthrough" by Dr. Mike Dow and Ronan Levy, the founder of Field Trip, the largest provider of psychedelic-assisted psychotherapies. They argue that ketamine, when combined with psychotherapy, has the potential to heal the brain and repair neurological damage caused by stress, anxiety, and abuse. The book provides an overview of ketamine-assisted psychotherapy, including its history, how it works, who it works for, and specific protocols for practitioners and patients. It offers hope for those with treatment-resistant depression, trauma, and addictions, and has been effective with couples, groups, and veterans. The book also includes a session-by-session Ketamine-Assisted Psychotherapy Workbook to enhance and deepen the treatment.

Format: Paperback / softback
Length: 248 pages
Publication date: 04 April 2023
Publisher: Hay House UK Ltd

The integration of ketamine into treatment for various mental health conditions, including depression, anxiety, PTSD, and more, is explored in a new book by Dr. Mike Dow, a best-selling author, and Ronan Levy, the founder of Field Trip, the world's largest provider of psychedelic-assisted psychotherapies. This breakthrough has been hailed as the most significant advancement in mental health since the introduction of Prozac in 1986.

While ketamine was once considered taboo, it is now experiencing a remarkable therapeutic resurgence. When used in conjunction with psychotherapy, ketamine has the potential to effectively treat depression, anxiety, PTSD, and other debilitating mental illnesses. Unlike traditional antidepressants, which merely mask the pain, psychedelics that heal the brain hold the promise of a new era in mental health care.

Ketamine Assisted-Psychotherapy (KAP) is a novel approach that aims to repair the neurological damage caused by stress, anxiety, neglect, and abuse. It works by targeting the brain's glutamate receptors, which play a crucial role in regulating mood and emotion. By administering low doses of ketamine, patients can experience a rapid and profound improvement in their symptoms.

In their book, "The Ketamine Breakthrough," Dr. Dow and Levy provide a comprehensive overview of KAP, including its origins, mechanisms of action, suitability for different populations, and practical protocols for practitioners and patients. They address the concerns surrounding ketamine use and offer hope to those who have struggled with treatment-resistant depression, trauma, and addictions.

KAP has shown effectiveness in treating a wide range of mental health conditions, including drug, alcohol, and behavioral addictions, existential depression, grief, and feelings of being stuck. It has also been found to be beneficial for individuals with unresolved resentments, anger, and everyday anxieties of modern life.

The use of ketamine in psychotherapy is still a relatively new field, and more research is needed to fully understand its long-term effects and potential side effects. However, the initial findings and anecdotal reports suggest that KAP holds great promise for improving the lives of those who suffer from mental health disorders.

In conclusion, the integration of ketamine into treatment for mental health conditions is a groundbreaking breakthrough that has the potential to transform the way we approach mental health care. While more research is needed to fully understand its long-term effects, the initial results and anecdotal reports suggest that KAP holds great promise for improving the lives of those who suffer from mental health disorders. As the field of psychedelic-assisted psychotherapy continues to evolve, we can expect to see further advancements and breakthroughs that will help more people find relief and healing.

Weight: 432g
Dimension: 177 x 230 x 23 (mm)
ISBN-13: 9781788178792